Clinical cure rates, in the pooled analysis, were statistically significantly greater for ibrexafungerp when compared with placebo (p < 0.0001). In the pooled analysis, patients receiving ...
The risk of major adverse cardiovascular events was comparable with placebo in patients not treated with dialysis who received the investigational drug roxadustat, according to pooled cardiovascular ...
Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation–Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic ...
CAMBRIDGE, Mass., Nov. 08, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ: NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based ...
The five medical centers overseen by the University of California have collected more than a decade's worth of surgical data, allowing it to streamline care and improve financial margins, which has ...
Conflicting findings in environmental epidemiology have long stalled consensus on the health effects of toxic chemicals. A new study suggests that one major reason for these inconsistencies may be the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback